v3.25.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
 1 Months Ended 6 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Feb. 28, 2021
Dec. 31, 2020
Nov. 30, 2018
Jun. 30, 2025
Regeneron Pharmaceuticals Inc [Member]            
Loss Contingencies [Line Items]            
Term of agreement     5 years      
BeiGene Swizerland Gmb H [Member]            
Loss Contingencies [Line Items]            
Term of agreement   7 years        
F.Hoffman La Roche Ltd [Member]            
Loss Contingencies [Line Items]            
Term of agreement 5 years          
Ateganosine THIO Therapeutics Inc [Member] | Amended Patent And Technology License Agreement [Member]            
Loss Contingencies [Line Items]            
Term of agreement         20 years  
Combined milestone payment maximum         $ 112,000,000  
Ateganosine THIO Therapeutics Inc [Member] | Amended Patent And Technology License Agreement [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Milestone payment         $ 1,000,000  
Ateganosine THIO Therapeutics Inc [Member] | Amended Patent And Technology License Agreement [Member] | Minimum [Member] | Net Sales Up to $1,000,000,000 [Member]            
Loss Contingencies [Line Items]            
Rate of royalties on net sales         2.00%  
Ateganosine THIO Therapeutics Inc [Member] | Amended Patent And Technology License Agreement [Member] | Minimum [Member] | Net Sales Above $1,000,000,000 [Member]            
Loss Contingencies [Line Items]            
Rate of royalties on net sales         2.50%  
Ateganosine THIO Therapeutics Inc [Member] | Amended Patent And Technology License Agreement [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Milestone payment         $ 50,000,000  
Ateganosine THIO Therapeutics Inc [Member] | Amended Patent And Technology License Agreement [Member] | Maximum [Member] | Net Sales Up to $1,000,000,000 [Member]            
Loss Contingencies [Line Items]            
Rate of royalties on net sales         4.00%  
Ateganosine THIO Therapeutics Inc [Member] | Amended Patent And Technology License Agreement [Member] | Maximum [Member] | Net Sales Above $1,000,000,000 [Member]            
Loss Contingencies [Line Items]            
Rate of royalties on net sales         5.00%  
University Of Texas Southwestern [Member] | Amended Patent And Technology License Agreement [Member]            
Loss Contingencies [Line Items]            
Payments due related to milestones           $ 0
University Of Texas Southwestern [Member] | Patent And Technology License Agreement [Member]            
Loss Contingencies [Line Items]            
Term of agreement       20 years    
Combined milestone payment maximum       $ 112,000,000    
Percentage of royalty description           There are single digit royalty rates for licensed products and licensed services covered by a Valid Claim (as defined in the UTSW2 Agreement) and dependent on whether Net Sales are greater than or less than/equal to $1,000,000,000, with Net Sales above that amount commanding a slightly higher percentage. In each case, the royalty percentage is lower before patent issuance in each jurisdiction. In the event that the licensed product or licensed service is not covered by a Valid Claim, the running royalty rates are reduced by 50%.
Claim expiration period       10 years    
University Of Texas Southwestern [Member] | Patent And Technology License Agreement [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Milestone payment       $ 1,000,000    
University Of Texas Southwestern [Member] | Patent And Technology License Agreement [Member] | Minimum [Member] | Net Sales Up to $1,000,000,000 [Member]            
Loss Contingencies [Line Items]            
Rate of royalties on net sales       2.00%    
University Of Texas Southwestern [Member] | Patent And Technology License Agreement [Member] | Minimum [Member] | Net Sales Above $1,000,000,000 [Member]            
Loss Contingencies [Line Items]            
Rate of royalties on net sales       2.50%    
University Of Texas Southwestern [Member] | Patent And Technology License Agreement [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Milestone payment       $ 50,000,000    
University Of Texas Southwestern [Member] | Patent And Technology License Agreement [Member] | Maximum [Member] | Net Sales Up to $1,000,000,000 [Member]            
Loss Contingencies [Line Items]            
Rate of royalties on net sales       4.00%    
University Of Texas Southwestern [Member] | Patent And Technology License Agreement [Member] | Maximum [Member] | Net Sales Above $1,000,000,000 [Member]            
Loss Contingencies [Line Items]            
Rate of royalties on net sales       5.00%